InnoCan Pharma Earnings Calls

Mar 31, 2026
Release date Mar 31, 2026
EPS estimate -
EPS actual -$0.210
Revenue estimate -
Revenue actual 6.375M

Last 1 Quarters for InnoCan Pharma

Below you can see how INNPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Mar 31, 2026
Release date Mar 31, 2026
Price on release $4.95
EPS estimate -
EPS actual -$0.210
Date Price
Mar 25, 2026 $4.95
Mar 26, 2026 $4.95
Mar 27, 2026 $4.95
Mar 30, 2026 $4.95
Mar 31, 2026 $4.95
Apr 01, 2026 $4.95
Apr 02, 2026 $4.95
Apr 06, 2026 $4.95
Apr 07, 2026 $4.95
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%

InnoCan Pharma Earnings History

Earnings Calendar

FAQ

What is the INNPF price-to-earnings (P/E) ratio?
INNPF P/E ratio as of Jun 18, 2026 (TTM) is -6.69.

What are InnoCan Pharma Corporation's retained earnings?
On its balance sheet, InnoCan Pharma Corporation reported retained earnings of $0 for the latest quarter ending Jun 30, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT INNOCAN PHARMA CORPORATION
InnoCan Pharma
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE